ATE290876T1 - Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil - Google Patents

Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil

Info

Publication number
ATE290876T1
ATE290876T1 AT00201627T AT00201627T ATE290876T1 AT E290876 T1 ATE290876 T1 AT E290876T1 AT 00201627 T AT00201627 T AT 00201627T AT 00201627 T AT00201627 T AT 00201627T AT E290876 T1 ATE290876 T1 AT E290876T1
Authority
AT
Austria
Prior art keywords
propylene glycol
cyclosprin
pharmaceutical composition
active ingredient
composition containing
Prior art date
Application number
AT00201627T
Other languages
English (en)
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Application granted granted Critical
Publication of ATE290876T1 publication Critical patent/ATE290876T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00201627T 2000-05-04 2000-05-04 Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil ATE290876T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00201627A EP1151755B1 (de) 2000-05-04 2000-05-04 Pharmazeutische Zusammensetzung enthaltend Cyclosprin als aktiven Bestandteil

Publications (1)

Publication Number Publication Date
ATE290876T1 true ATE290876T1 (de) 2005-04-15

Family

ID=8171456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00201627T ATE290876T1 (de) 2000-05-04 2000-05-04 Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil

Country Status (6)

Country Link
EP (1) EP1151755B1 (de)
AT (1) ATE290876T1 (de)
DE (1) DE60018715T2 (de)
DK (1) DK1151755T3 (de)
ES (1) ES2235765T3 (de)
PT (1) PT1151755E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2005037250A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self emulsifying drug delivery systems for hydrophobic therapeutic compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
WO2005105041A2 (en) * 2004-04-27 2005-11-10 Formatech, Inc. Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
TW200824686A (en) * 2006-10-31 2008-06-16 Wyeth Corp Formulations of phospholipase enzyme inhibitors
US9402812B2 (en) 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
ITMI20111050A1 (it) * 2011-06-10 2012-12-11 Sevecom Spa Uso di emulsionanti in associazione con oleine vegetali in un alimento per animali.
CA2954590C (en) 2014-07-21 2023-09-19 Sevecom S.P.A. Powdered emulsion for animal feed

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
ATE262916T1 (de) * 1998-08-18 2004-04-15 Panacea Biotec Ltd Zusammensetzung enthalten cyclsoporin in einem hydrophilen träger

Also Published As

Publication number Publication date
EP1151755B1 (de) 2005-03-16
DK1151755T3 (da) 2005-06-27
EP1151755A1 (de) 2001-11-07
ES2235765T3 (es) 2005-07-16
DE60018715T2 (de) 2006-04-27
DE60018715D1 (de) 2005-04-21
PT1151755E (pt) 2005-05-31

Similar Documents

Publication Publication Date Title
CO4761073A1 (es) Preparados que contienen ciclosporina
EE05256B1 (et) Ravimpreparaat, milles aktiivne ingredient on ühtlaselt dispergeeritud abiainete alussegus, ning seda sisaldav doseerimisvorm
AP2000001943A0 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
ATE290876T1 (de) Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil
DE69921409D1 (de) Cyclosporin enthaltende Zusammensetzungen
MX9800188A (es) Composiciones topicas estables.
CA2166388A1 (en) Antifungal composition for external use retentive in stratum corneum
CO5140102A1 (es) Formulacion farmaceutica en forma de pasta semisolida estabilizada para administracion oral que comprende omeprazol, de dos a cuatro agentes basificantes, un agente espesante y un vehiculo aceitoso hidrofobico
WO2003032933A8 (de) Kosmetische und/oder pharmazeutische rückfettende zubereitungen
AU6087699A (en) Agent for repelling and inactivating pathogenic organisms of plants
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
FI955403A (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
AU692801B2 (en) Pharmaceutical compositions comprising a staurosporine as active ingredient.
DE60135927D1 (en) Nd
ATE279199T1 (de) Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
EA200200415A1 (ru) Композиция фармацевтического носителя
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
BR9802667C2 (pt) Composições farmacêuticas contendo ciclosporina como ingrediente ativo
RU99121398A (ru) Фармацевтические композиции
RU2002116010A (ru) Антисептическое средство "АХДЕЗ 3000"
AR034494A1 (es) Composiciones para el tratamiento del cabello.
GR1001364B (el) Από του στόματος συν?έσεις ουβιδεκαρενόνης υπό μορφήν υδατικών διαλυμάτων.
TH33847A (th) องค์ประกอบทางเภสัช
GEP20012464B (en) Compositions Comprising an HIV Protease Inhibitor Such As VX 478 and a Water Soluble Vitamin E Compound Such As Vitamin E-TPGS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1151755

Country of ref document: EP

REN Ceased due to non-payment of the annual fee